IL10 and type 1 diabetes mellitus: A clinical trial is currently underway to assess the safety and tolerability of AG019, L. lactis delivering human PINS and IL-10, administered alone or in combination with Teplizumab in newly diagnosed T1D patients (ClinicalTrials.gov Identifier: NCT03751007).